President’s Letter | July 2021
…melanoma research through our International Melanoma Tissue Bank Consortium and other projects. We can’t repeat it enough times: Melanoma research…
President’s Letter | July 2021
…melanoma research through our International Melanoma Tissue Bank Consortium and other projects. We can’t repeat it enough times: Melanoma research…
,
Melanoma By The State: Arizona
…Melanoma Task Force In 2011, the Arizona Melanoma Task Force, a coalition of Arizona stakeholders, was formed to determine whether…
,
Adjuvant Immunotherapy Prolongs Recurrence-Free Survival in Resected Stage II B/C Melanoma
…the melanoma comes back.” Hamid noted that the dose frequency and duration of adjuvant therapy in stage II B/C melanoma…
,
,
COVID-19 Has Created a Backlog of Undiagnosed Cancers, Including Melanoma
…part of an organized program (like melanoma). Melanoma was particularly impacted. Along with cervical, endocrine, and prostate cancer, melanoma was…
,
Immunocore announces clinical trial collaboration with Sanofi to evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2, in combination with KIMMTRAK® in patients with metastatic cutaneous melanoma
…regulatory T cells KIMMTRAK, gp100 x CD3 ImmTAC bispecific protein, approved in metastatic uveal melanoma and demonstratedpromising survival data in metastatic cutaneous melanoma (OXFORDSHIRE, England & CONSHOHOCKEN,…
,
Pembrolizumab in the Neoadjuvant Setting Benefits EFS in High-Risk Melanoma
…The study, known as S1801, was led by Sapna Patel, MD, chair of the SWOG melanoma committee and associate professor…
,
From a Scare to Awareness: Lindsay Willis’s Mission to Educate on Melanoma Risks
…Lindsay’s mom thought about her own history with pre-melanomas and insisted her daughter’s mole be removed, just in case. “Thankfully…
,
Announcing AIM at Melanoma’s Official Sunscreen Partner, WearSPF
…are on a mission to educate and encourage people of all ages to, literally, wear SPF—and to get their skin…
Understanding Tumor Genetics and Melanoma: A Recap of Our Latest Webinar
…Research Center, she leads early-phase clinical trials for advanced and treatment-resistant melanoma. Her research focuses on targeting resistance mechanisms to…
,
President’s Letter | December 2021
…part of the AIM’s Melanoma International Patient Advocacy Coalition. This month we’re featuring North Carolina in our Melanoma by the…
,
Recent Posts
Jun. 09, 2026
The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026